First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
664
total citations
- FWCI
- 11.55
- Percentile
- 100%
- References
- 19
Citations per year
Authors
8Topics & keywords
Topics
Keywords
- Ex vivo
- Graft-versus-host disease
- IL-2 receptor
- Interleukin-7 receptor
- Immunology
- Immunosuppression
- Medicine
- In vivo
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.